Clinical Trials Directory

Trials / Completed

CompletedNCT06322615

Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy

Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the feasibility of a nurse- and patient-applied acupressure intervention for patients with anxiety associated with active cancer-directed therapy. II. Patient-reported changes in acute anxiety associated with both the nurse and self-led acupressure interventions will be ascertained. OUTLINE: Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home. After completion of study intervention, patients who opted to receive education about using acupressure at home are followed up at 1 week.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcupressure TherapyUndergo acupressure
OTHEREducational InterventionReceive education session about using acupressure at home
OTHERElectronic Health Record ReviewAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2023-08-08
Primary completion
2024-01-29
Completion
2024-02-01
First posted
2024-03-21
Last updated
2025-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06322615. Inclusion in this directory is not an endorsement.